Impact of fractionated stereotactic radiotherapy on activity of daily living and performance status in progressive/recurrent glioblastoma: a retrospective study

被引:0
作者
Nicolas Demogeot
J. Salleron
F. Rech
L. Taillandier
P. Royer
G. Vogin
机构
[1] Institut de Cancérologie de Lorraine– Alexis-Vautrin CLCC (Centre de Lutte Contre le Cancer – Cancer Center) – Unicancer,Academic Department of Radiation Therapy and Brachytherapy
[2] Institut de Cancérologie de Lorraine,Department of Biostatistics and Data Management
[3] CHU de Nancy,Department of Neurosurgery
[4] CHU de Nancy,Department of Neuro
[5] Centre d’Oncologie de Gentilly,Oncology
[6] Centre François Baclesse,Department of Radiation Oncology
来源
Radiation Oncology | / 17卷
关键词
Glioblastoma; Recurrence; Karnofsky performance status; Cyberknife; Stereotactic radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 265 条
[1]  
Nabors LB(2020)Central nervous system cancers, version 3.2020, NCCN Clinical Practice Guidelines in Oncology J Natl Compr Canc Netw 18 1537-1570
[2]  
Portnow J(2021)EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood Nat Rev Clin Oncol 18 170-186
[3]  
Ahluwalia M(2017)European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma Lancet Oncol 18 e330-e340
[4]  
Baehring J(2020)Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions Neuro Oncol 22 1073-1113
[5]  
Brem H(2019)Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis J Neurooncol 142 79-90
[6]  
Brem S(2019)Survival benefit of maximal resection for glioblastoma reoperation in the temozolomide era: a meta-Analysis World Neurosurg 127 31-37
[7]  
Weller M(2018)Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma—the GlioCave study (NOA 17–ARO 2016/3–DKTK ROG trial) BMC Cancer 18 15-259
[8]  
van den Bent M(2018)Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups Radiother Oncol 128 254-127
[9]  
Preusser M(2018)Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: a multicenter DKTK/ROG analysis Radiother Oncol 127 121-399
[10]  
Le Rhun E(2017)Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma PLoS ONE 12 e0180457-294